The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) revealed that longitudinal CA125 testing combined with annual TVUS screening improved the recognition capability for early-stage ovarian cancer by 47%. Here, MUC16 is linked to ovarian cancer.